NDC product
VIMKUNYA
NDC 50632-018 · Bavarian Nordic A/S
Key facts
| Product NDC | 50632-018 |
|---|---|
| Proprietary name | VIMKUNYA |
| Nonproprietary name | Chikungunya Vaccine, Recombinant |
| Substances | CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 CAPSID PROTEIN, CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E1, CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E2 |
| Dosage form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Labeler | Bavarian Nordic A/S |
| Product type | VACCINE |
| Marketing category | BLA |
| Application number | BLA125820 |
| Marketing start | Mar 1, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: